나노로보틱스 시장 : 유형별(나노 매니퓰레이터, 나노 로보틱 시스템), 도입 형태별(생체내, 체외/생체외, 기타), 기술별(자기 구동, 바이오하이브리드/생물 추진, 음향/초음파 추진, 기타) - 세계 예측(-2032년)

Nanorobotics Market by Type (Nano-manipulator, Nanorobotic System), Deployment (In-vivo, In-vitro/Ex-vivo, Others), Technology (Magnetic Actuation, Biohybrid/Biological Propulsion, Acoustic/Ultrasound Propulsion, Others)-Global Forecast to 2032

US $ 4,950 ￦ 7,162,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,621,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,792,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,469,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 나노로보틱스 시장 규모는 2025년 22억 7,000만 달러에서 2032년까지 45억 2,000만 달러로 성장하여 2026년부터 2032년까지 CAGR 10.6%로 확대될 것으로 예측됩니다.

조사 범위
조사 대상 기간	2021-2032년
기준 연도	2024년
예측 기간	2025-2032년
단위	금액(달러)
부문	유형별, 도입 형태별, 기술별, 지역별
대상 지역	북미, 유럽, 아시아태평양, 기타 지역

나노로보틱스 시장의 성장은 나노기술 연구개발에 대한 정부 및 민간의 투자 증가와 연구기관과 업계 관계자들 간의 협력 확대에 의해 촉진될 것으로 예상됩니다. 이는 기술 개발을 가속화하고 있습니다. 또한, 재료과학, 반도체 연구, 나노스케일 제조에서 나노 로봇 공학의 활용 확대도 시장 확대를 뒷받침하고 있습니다.

"유형별로는 나노 매니퓰레이터 부문이 예측 기간 동안 가장 큰 점유율을 차지할 것으로 예상됩니다."

나노 매니퓰레이터는 나노스케일에서 정밀한 위치 결정, 프로빙, 조작을 위한 확립된 도구로 재료과학, 반도체 연구, 생명과학 연구에 필수적인 도구입니다. 이러한 확고한 입지는 입증된 성능, 비교적 높은 기술 성숙도, 기존 연구 워크플로우에 대한 원활한 통합으로 뒷받침됩니다. 또한, 학술 기관 및 산업 분야의 고정밀 나노스케일 분석 및 실험에 대한 지속적인 수요가 대규모 도입을 촉진하고 있으며, 나노 로봇 시장에서 나노 매니퓰레이터의 지배적인 점유율을 더욱 강화하고 있습니다.

"예측 기간 동안 제약 및 생명공학 기업 부문이 가장 높은 CAGR을 기록할 것으로 예상됩니다."

제약 및 생명공학 기업 부문은 첨단 의약품 개발 및 정밀 치료 기술에 대한 수요 증가에 힘입어 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다. 제약 및 생명공학 기업들은 치료 효과를 높이고 부작용을 줄이기 위해 표적 약물전달, 나노 수술, 조직 복구, 생체 내 연구를 위해 나노 로봇 공학 시스템의 채택을 확대하고 있습니다. 생물학적 제제, 재생의료, 맞춤치료에 대한 투자가 증가하면서 정밀하고 제어 가능한 나노스케일 솔루션의 필요성이 가속화되고 있습니다.

"아시아태평양에서 중국이 가장 큰 나노로보틱스 시장이 될 것으로 예상됩니다."

예측 기간 동안 중국은 아시아태평양의 나노 로봇 시장을 계속 주도할 것으로 예상됩니다. 중국에는 나노로보틱스 개발에 적극적인 대학, 국립연구소, 연구기관으로 구성된 탄탄한 생태계가 구축되어 있으며, in vitro(시험관 내) 및 in vivo(생체 내) 응용을 모두 지원하고 있습니다. 또한, 중국의 제약 및 생명공학 산업은 약물전달, 진단 및 차세대 의료 연구 분야에서 나노 로봇 공학의 채택을 가속화하고 있습니다. 강력한 정책적 지원, 증가하는 R&D 투자, 긴밀한 산학협력이 중국의 선도적 입지를 더욱 강화하여 아시아태평양의 나노 로봇 시장 성장의 주요 동력이 되고 있습니다.

세계의 나노로보틱스 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 각종 영향요인 분석, 기술·특허 동향, 법·규제 환경, 사례 분석, 시장 규모 추정 및 예측, 각종 부문별·지역별·주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 소개

제2장 주요 요약

제3장 주요 인사이트

제4장 시장 개요

제5장 업계 동향

제6장 기술의 진보, AI 기반 영향력, 특허, 혁신, 향후 응용

제7장 규제 상황

제8장 고객 상황과 구매 행동

제9장 나노로보틱스 시장 : 유형별

제10장 나노로보틱스 시장 : 기술별

제11장 나노로보틱스 시장 : 도입 형태별

제12장 나노로보틱스 시장 : 용도별

제13장 나노로보틱스 시장 : 최종사용자별

제14장 나노로보틱스 시장 : 지역별

제15장 경쟁 구도

제16장 기업 개요

제17장 조사 방법

제18장 부록

KSM

영문 목차

영문목차

The global nanorobotics market is projected to grow from USD 2.27 billion in 2025 to USD 4.52 billion by 2032, at a CAGR of 10.6% from 2026 to 2032.

Scope of the Report
Years Considered for the Study	2021-2032
Base Year	2024
Forecast Period	2025-2032
Units Considered	Value (USD Billion)
Segments	By Type, Deployment, Technology and Region
Regions covered	North America, Europe, APAC, RoW

The growth of the nanorobotics market is expected to be driven by rising government and private investments in nanotechnology R&D, along with expanding collaboration between research institutes and industry players, which are accelerating technology development. In addition, increasing use of nanorobotics in materials science, semiconductor research, and nanoscale manufacturing is supporting market expansion.

"By type, the nano-manipulator segment holds the largest share during the forecast period."

The nano-manipulators segment of the nanorobotics market is expected to hold the largest market share during the forecast period. Nano-manipulators are well-established tools for precise positioning, probing, and manipulation at the nanoscale, making them essential for materials science, semiconductor research, and life-science studies. Their strong market presence is supported by proven performance, relatively higher technology maturity, and seamless integration into existing research workflows. In addition, continuous demand for high-precision nanoscale analysis and experimentation across academic and industrial settings continues to drive large-scale adoption, reinforcing nano-manipulators' dominant share in the global nanorobotics market.

"Pharma & biotech companies segment expected to register the highest CAGR during the forecast period."

The pharma & biotech companies segment is expected to grow at the highest CAGR during the forecast period, driven by growing demand for advanced drug development and precision treatment technologies. Pharma and biotech companies are increasingly adopting nanorobotics systems for targeted drug delivery, nanosurgery, tissue repair, and in vivo research to improve therapeutic efficacy and reduce side effects. Rising investments in biologics, regenerative medicine, and personalized therapies are accelerating the need for exact and controllable nanoscale solutions.

"China to be the largest market for nanorobotics in the Asia Pacific."

China is expected to continue dominating the nanorobotics market in the Asia Pacific region during the forecast period. The country has established a robust ecosystem of universities, national laboratories, and research institutes actively engaged in nanorobotics development, supporting both in vitro and in vivo applications. In addition, China's growing pharmaceutical and biotechnology industries are accelerating the adoption of nanorobotics for drug delivery, diagnostics, and next-generation medical research. Strong policy support, increasing R&D investments, and close collaboration between academia and industry further strengthen China's leadership position, making it the dominant contributor to nanorobotics market growth in the Asia Pacific region.

Extensive primary interviews were conducted with key industry experts in the nanorobotics market to determine and verify market sizes across segments and subsegments. The breakdown of primary participants for the report is shown below. The study includes insights from various industry experts, including component suppliers, Tier 1 Companies, and OEMs. The breakup of the primaries is as follows:

• By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 - 35%
• By Designation: C-level Executives - 35%, Directors - 340%, and Others - 20%
• By Region: North America - 25%, Europe - 20%, Asia Pacific - 45%, and RoW - 10%

Note: Three tiers of companies are defined based on their total revenue as of 2024: tier 1: revenue of USD 500 million or more; tier 2: revenue between USD 100 million and USD 500 million; and tier 3: revenue of USD 100 million or less. Other designations include sales and marketing executives, researchers, and members of various nanorobotics organizations.

JEOL LTD. (Japan), Thermo Fisher Scientific Inc. (US), Bruker (Germany), Hitachi High-Tech Corporation (Japan), ZEISS Group (Germany), Oxford Instruments (UK), EV Group (Austria), Park Systems (South Korea), among others, are the key players in the nanorobotics market. The study includes an in-depth competitive analysis of these key players in the nanorobotics market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

This research report categorizes the nanorobotics market by type (nano-manipulators and nanorobotics systems), deployment (in vivo, in vitro/ex vivo, and other), technology (magnetic actuation, biohybrid/biological propulsion, acoustic/ultrasound propulsion, and other), application (drug delivery, diagnostics, nano-surgery & tissue repair, and other), end user (hospitals & clinical centers, pharma & biotech companies, research institutes & universities, medical devices OEMs, and other), and region (North America, Europe, Asia-Pacific, and RoW). The report describes the major drivers, restraints, challenges, and opportunities in the nanorobotics market and forecasts the market through 2032. The report also includes leadership mapping and analysis of all the companies included in the nanorobotics market ecosystem.

Key Benefits of Buying the Report

The report will help the market leaders/new entrants in this market by providing information on the closest approximations of the revenue numbers for the overall nanorobotics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

• Analysis of key drivers (rising focus on nanotechnology and regenerative medicine and increasing government support and level of investment in nanorobotics) restraints (Lack of clear regulatory frameworks and high development & manufacturing costs), opportunities (growing demand of oncology and precision therapeutics and increasing use of AI-guided imaging systems enhancing nanorobotics navigation and monitoring) and challenges (commercialization of nanorobotics systems) influencing the growth of the nanorobotics market
• Product Development/Innovation: Detailed insights into upcoming technologies, research and development activities, and the latest product and service launches in the nanorobotics market
• Market Development: Comprehensive information about lucrative markets - the report analyzes the nanorobotics market across varied regions
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the nanorobotics market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as JEOL LTD. (Japan), Thermo Fisher Scientific Inc. (US), Bruker (Germany), Hitachi High-Tech Corporation (Japan), ZEISS Group (Germany), Oxford Instruments (UK), EV Group (Austria), Park Systems (South Korea), among others in the nanorobotics market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
  • 1.3.5 UNIT CONSIDERED
• 1.4 STAKEHOLDERS

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING NANOROBOTICS MARKET
• 2.4 HIGH-GROWTH SEGMENTS
• 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NANOROBOTICS MARKET
• 3.2 NANOROBOTICS MARKET, BY TYPE
• 3.3 NANOROBOTICS MARKET, BY APPLICATION
• 3.4 NANOROBOTICS MARKET, BY TECHNOLOGY
• 3.5 NANOROBOTICS MARKET, BY END USER
• 3.6 NANOROBOTICS MARKET, BY COUNTRY

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Strong healthcare demand for better clinical translation and investment
    • 4.2.1.2 Increasing government support and level of investment in nanorobotics
    • 4.2.1.3 Rising focus on nanotechnology and regenerative medicine
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 Lack of clear regulatory frameworks and high development & manufacturing costs
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Growing demand of oncology and precision therapeutics
    • 4.2.3.2 Increasing use of AI-guided imaging systems, enhancing nanorobotics navigation and monitoring
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Commercialization of nanorobotics systems
• 4.3 UNMET NEEDS & WHITE SPACES
  • 4.3.1 UNMET NEEDS IN NANOROBOTICSS MARKET
  • 4.3.2 WHITE SPACE OPPORTUNITIES
• 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
  • 4.4.1 INTERCONNECTED MARKETS
  • 4.4.2 CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
  • 4.5.1 MARKET DYNAMICS FOR NANOROBOTICS MARKET

5 INDUSTRY TRENDS

• 5.1 INTRODUCTION
• 5.2 PORTER'S FIVE FORCES ANALYSIS
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 THREAT OF SUBSTITUTES
  • 5.2.3 BARGAINING POWER OF SUPPLIERS
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.3 MACROECONOMIC OUTLOOK
  • 5.3.1 INTRODUCTION
  • 5.3.2 GDP TRENDS AND FORECAST
  • 5.3.3 TRENDS IN GLOBAL MEDICAL OEMS
  • 5.3.4 TRENDS IN GLOBAL HOSPITALS AND CLINICAL CENTERS
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 ECOSYSTEM ANALYSIS
  • 5.5.1 ROLE IN ECOSYSTEM
• 5.6 PRICING ANALYSIS
  • 5.6.1 AVERAGE SELLING PRICE FOR ELECTRON MICROSCOPES, BY TYPE, 2025
  • 5.6.2 AVERAGE SELLING PRICE TREND OF ELECTRON MICROSCOPES, BY TYPE, 2022-2025
  • 5.6.3 AVERAGE SELLING PRICE TREND OF SEM ELECTRON MICROSCOPES, BY REGION, 2022-2025
• 5.7 TRADE ANALYSIS
  • 5.7.1 IMPORT DATA FOR HS CODE 901210
  • 5.7.2 EXPORT DATA FOR HS CODE 901210
• 5.8 KEY CONFERENCES & EVENTS, 2026-2027
• 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 5.10 INVESTMENT & FUNDING SCENARIO, 2023-2025
• 5.11 CASE STUDY ANALYSIS
  • 5.11.1 KLEINDIEK NANOTECHNIK ENABLING IN-SITU NANO-MANIPULATION INSIDE SEM AND TEM
• 5.12 IMPACT OF 2025 US TARIFF ON NANOROBOTICS MARKET
  • 5.12.1 KEY TARIFF RATES
  • 5.12.2 PRICE IMPACT ANALYSIS
  • 5.12.3 IMPACT ON VARIOUS COUNTRIES/REGIONS
    • 5.12.3.1 US
    • 5.12.3.2 Europe
    • 5.12.3.3 Asia Pacific
  • 5.12.4 IMPACT ON END USERS

6 TECHNOLOGICAL ADVANCEMENT, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 6.1 KEY TECHNOLOGIES
  • 6.1.1 NANOMEDICINE AND PRECISION DRUG DELIVERY SYSTEMS
  • 6.1.2 BIO-HYBRID AND CELL-DRIVEN NANOROBOTS
• 6.2 COMPLEMENTARY TECHNOLOGIES
  • 6.2.1 ADVANCED MEDICAL IMAGING AND NAVIGATION SYSTEMS
  • 6.2.2 ARTIFICIAL INTELLIGENCE & MACHINE LEARNING
• 6.3 ADJACENT TECHNOLOGIES
  • 6.3.1 LAB-ON-A-CHIP DEVICES
• 6.4 TECHNOLOGY/PRODUCT ROADMAP
• 6.5 PATENT ANALYSIS
  • 6.5.1 LIST OF APPLIED/GRANTED PATENTS
• 6.6 IMPACT OF AI/GEN AI ON NANOROBOTICS MARKET
  • 6.6.1 TOP USE CASES AND MARKET POTENTIAL
  • 6.6.2 BEST PRACTICES IN NANOROBOTICS MARKET
  • 6.6.3 CASE STUDIES OF AI IMPLEMENTATION
  • 6.6.4 INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS
  • 6.6.5 CLIENTS' READINESS TO ADOPT AI

7 REGULATORY LANDSCAPE

• 7.1 INTRODUCTION
• 7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 7.3 STANDARDS AND REGULATIONS RELATED TO NANOROBOTICS
  • 7.3.1 STANDARDS
    • 7.3.1.1 ISO
    • 7.3.1.2 REACH
    • 7.3.1.3 NIOSH

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

• 8.1 DECISION-MAKING PROCESS
• 8.2 KEY STAKEHOLDERS & BUYING CRITERIA
  • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.2.2 BUYING CRITERIA
• 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 8.4 UNMET NEEDS FROM VARIOUS END USERS

9 NANOROBOTICS MARKET, BY TYPE

• 9.1 INTRODUCTION
• 9.2 NANO-MANIPULATORS
  • 9.2.1 ADVANCEMENTS IN NANO-MANIPULATION TECHNOLOGIES TO ACCELERATE RESEARCH AND INDUSTRIAL ADOPTION
• 9.3 NANOROBOTIC SYSTEMS
  • 9.3.1 RISING FOCUS ON AUTONOMOUS NANOROBOTICS SYSTEMS TO AID MARKET EXPANSION

10 NANOROBOTICS MARKET, BY TECHNOLOGY

• 10.1 INTRODUCTION
• 10.2 MAGNETIC ACTUATION
  • 10.2.1 GROWTH OF HEALTHCARE SECTOR TO DRIVE DEMAND FOR MAGNETICALLY ACTUATED NANOROBOTICS
• 10.3 BIOHYBRID/BIOLOGICAL PROPULSION
  • 10.3.1 INCREASING FOCUS ON BIOCOMPATIBLE AND AUTONOMOUS NANOROBOTIC SYSTEMS TO PROPEL MARKET GROWTH
• 10.4 ACOUSTIC/ULTRASOUND PROPULSION
  • 10.4.1 ADVANCEMENTS IN NON-CONTACT TECHNOLOGIES TO SUPPORT ADOPTION OF ACOUSTIC/ULTRASOUND PROPULSION
• 10.5 OTHER TECHNOLOGIES

11 NANOROBOTICS MARKET, BY DEPLOYMENT

• 11.1 INTRODUCTION
• 11.2 IN-VIVO DEPLOYMENT
  • 11.2.1 RISING INVESTMENT IN NANOMEDICINE AND TRANSLATIONAL RESEARCH TO AID MARKET GROWTH
• 11.3 IN-VITRO/EX-VIVO DEPLOYMENT
  • 11.3.1 CONTINUOUS INVESTMENTS IN LIFE-SCIENCE RESEARCH AND MATERIALS INNOVATION TO AUGMENT MARKET GROWTH
• 11.4 OTHER DEPLOYMENTS

12 NANOROBOTICS MARKET, BY APPLICATION

• 12.1 INTRODUCTION
• 12.2 DIAGNOSTICS
  • 12.2.1 GROWING ADOPTION OF IN-VITRO DIAGNOSTICS, LAB-ON-CHIP, AND POINT-OF-CARE TESTING TO BOOST MARKET GROWTH
• 12.3 DRUG DELIVERY
  • 12.3.1 INCREASING PREVALENCE OF CHRONIC AND COMPLEX DISEASES TO FUEL MARKET GROWTH
• 12.4 NANO SURGERY & TISSUE REPAIR
  • 12.4.1 RISING DEMAND FOR MINIMALLY INVASIVE AND HIGH-PRECISION SURGICAL INTERVENTIONS TO PROPEL MARKET GROWTH
• 12.5 OTHER APPLICATIONS

13 NANOROBOTICS MARKET, BY END USER

• 13.1 INTRODUCTION
• 13.2 RESEARCH INSTITUTES & UNIVERSITIES
  • 13.2.1 DEMAND FOR NANO-MANIPULATORS, NANOPROBING SYSTEMS, AND EXPERIMENTAL NANOROBOTIC PLATFORMS TO DRIVE MARKET
• 13.3 HOSPITALS & CLINICAL CENTERS
  • 13.3.1 RISING DEMAND FOR MINIMALLY INVASIVE AND PRECISION-GUIDED MEDICAL PROCEDURES TO AID MARKET GROWTH
• 13.4 PHARMA & BIOTECH COMPANIES
  • 13.4.1 RISING R&D SPENDING TO IMPROVE DRUG DISCOVERY EFFICIENCY AND SUCCESS RATES
• 13.5 MEDICAL OEMS
  • 13.5.1 DEMAND FOR MINIATURIZED AND HIGH-PRECISION MEDICAL DEVICES AND COMPONENTS TO AUGMENT MARKET GROWTH
• 13.6 OTHER END USERS

14 NANOROBOTICS MARKET, BY REGION

• 14.1 INTRODUCTION
• 14.2 NORTH AMERICA
  • 14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 14.2.2 US
    • 14.2.2.1 Early adoption of advanced medical technologies to support market growth
  • 14.2.3 CANADA
    • 14.2.3.1 Government funding and healthcare innovation to drive Canadian nanorobotics market
  • 14.2.4 MEXICO
    • 14.2.4.1 Strategic partnerships and nanotechnology platforms to fuel market growth
• 14.3 EUROPE
  • 14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 14.3.2 UK
    • 14.3.2.1 Growing nanotechnology development programs to boost market demand
  • 14.3.3 GERMANY
    • 14.3.3.1 Growing nanotechnology research to improve market growth
  • 14.3.4 FRANCE
    • 14.3.4.1 Investments in research & development to fuel market growth
  • 14.3.5 ITALY
    • 14.3.5.1 Rising focus on precision healthcare and research infrastructure to support market growth
  • 14.3.6 REST OF EUROPE
• 14.4 ASIA PACIFIC
  • 14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 14.4.2 CHINA
    • 14.4.2.1 Growing number of collaborations for R&D in nanotechnology and life sciences to drive market
  • 14.4.3 JAPAN
    • 14.4.3.1 Rising R&D funding for biotechnology and nanotechnology to support market growth
  • 14.4.4 INDIA
    • 14.4.4.1 Increasing demand for advanced medical treatments to drive market
  • 14.4.5 SOUTH KOREA
    • 14.4.5.1 Increasing use in medical research and healthcare applications to fuel market demand
  • 14.4.6 REST OF ASIA PACIFIC
• 14.5 REST OF THE WORLD
  • 14.5.1 MACROECONOMIC OUTLOOK FOR REST OF THE WORLD
  • 14.5.2 MIDDLE EAST & AFRICA
    • 14.5.2.1 Rising oil & gas exploration activities to accelerate market growth
    • 14.5.2.2 GCC countries
    • 14.5.2.3 Rest of Middle East & Africa
  • 14.5.3 SOUTH AMERICA
    • 14.5.3.1 Growth in automotive, oil & gas, chemicals, and mining industries to augment market demand

15 COMPETITIVE LANDSCAPE

• 15.1 INTRODUCTION
• 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2025
• 15.3 MARKET SHARE ANALYSIS, 2024
• 15.4 REVENUE ANALYSIS, 2022-2024
• 15.5 COMPANY VALUATION & FINANCIAL METRICS
  • 15.5.1 COMPANY VALUATION
  • 15.5.2 FINANCIAL METRICS
• 15.6 BRAND/PRODUCT COMPARISON
• 15.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 15.7.1 STARS
  • 15.7.2 EMERGING LEADERS
  • 15.7.3 PERVASIVE PLAYERS
  • 15.7.4 PARTICIPANTS
  • 15.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 15.7.5.1 Company footprint
    • 15.7.5.2 Region footprint
    • 15.7.5.3 Type footprint
    • 15.7.5.4 Deployment footprint
    • 15.7.5.5 End-user footprint
• 15.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 15.8.1 PROGRESSIVE COMPANIES
  • 15.8.2 RESPONSIVE COMPANIES
  • 15.8.3 DYNAMIC COMPANIES
  • 15.8.4 STARTING BLOCKS
  • 15.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 15.8.5.1 Detailed list of key startups/SMEs
    • 15.8.5.2 Competitive benchmarking of key startups/SMEs
• 15.9 COMPETITIVE SCENARIO
  • 15.9.1 PRODUCT LAUNCHES
  • 15.9.2 DEALS
  • 15.9.3 OTHER DEVELOPMENTS

16 COMPANY PROFILES

• 16.1 KEY PLAYERS
  • 16.1.1 BRUKER
    • 16.1.1.1 Business overview
    • 16.1.1.2 Products/Solutions/Services offered
    • 16.1.1.3 Recent developments
      • 16.1.1.3.1 Product launches
      • 16.1.1.3.2 Deals
    • 16.1.1.4 MnM view
      • 16.1.1.4.1 Key strengths
      • 16.1.1.4.2 Strategic choices
      • 16.1.1.4.3 Weaknesses & competitive threats
  • 16.1.2 JEOL LTD.
    • 16.1.2.1 Business overview
    • 16.1.2.2 Products/Solutions/Services offered
    • 16.1.2.3 Recent developments
      • 16.1.2.3.1 Product launches
    • 16.1.2.4 MnM view
      • 16.1.2.4.1 Key strengths
      • 16.1.2.4.2 Strategic choices
      • 16.1.2.4.3 Weaknesses & competitive threats
  • 16.1.3 THERMO FISHER SCIENTIFIC INC.
    • 16.1.3.1 Business overview
    • 16.1.3.2 Products/Solutions/Services offered
    • 16.1.3.3 Recent developments
      • 16.1.3.3.1 Product launches
    • 16.1.3.4 MnM view
      • 16.1.3.4.1 Key strengths
      • 16.1.3.4.2 Strategic choices
      • 16.1.3.4.3 Weaknesses & competitive threats
  • 16.1.4 HITACHI HIGH-TECH CORPORATION
    • 16.1.4.1 Business overview
    • 16.1.4.2 Products/Solutions/Services offered
    • 16.1.4.3 Recent developments
      • 16.1.4.3.1 Product launches
      • 16.1.4.3.2 Deals
    • 16.1.4.4 MnM view
      • 16.1.4.4.1 Key strengths
      • 16.1.4.4.2 Strategic choices
      • 16.1.4.4.3 Weaknesses & competitive threats
  • 16.1.5 ZEISS GROUP
    • 16.1.5.1 Business overview
    • 16.1.5.2 Products/Solutions/Services offered
    • 16.1.5.3 Recent developments
      • 16.1.5.3.1 Product launches
      • 16.1.5.3.2 Deals
      • 16.1.5.3.3 Expansions
    • 16.1.5.4 MnM view
      • 16.1.5.4.1 Key strengths
      • 16.1.5.4.2 Strategic choices
      • 16.1.5.4.3 Weaknesses & competitive threats
  • 16.1.6 PARK SYSTEMS
    • 16.1.6.1 Business overview
    • 16.1.6.2 Products/Solutions/Services offered
    • 16.1.6.3 Recent developments
      • 16.1.6.3.1 Product launches
      • 16.1.6.3.2 Deals
      • 16.1.6.3.3 Expansions
  • 16.1.7 OXFORD INSTRUMENTS
    • 16.1.7.1 Business overview
    • 16.1.7.2 Products/Solutions/Services offered
  • 16.1.8 EV GROUP (EVG)
    • 16.1.8.1 Business overview
    • 16.1.8.2 Products/Solutions/Services offered
  • 16.1.9 THERANAUTILUS
    • 16.1.9.1 Business overview
    • 16.1.9.2 Products/Solutions/Services offered
  • 16.1.10 CIQTEK CO., LTD.
    • 16.1.10.1 Business overview
    • 16.1.10.2 Products/Solutions/Services offered
    • 16.1.10.3 Recent developments
      • 16.1.10.3.1 Product launches
      • 16.1.10.3.2 Deals
• 16.2 OTHER PLAYERS
  • 16.2.1 IMINA TECHNOLOGIES SA
  • 16.2.2 NANOBIOTIX
  • 16.2.3 NANOLIVE
  • 16.2.4 TORONTO NANO INSTRUMENTATION INC.
  • 16.2.5 KLOCKE NANOTECHNIK GMBH
  • 16.2.6 KLEINDIEK NANOTECHNIK GMBH
  • 16.2.7 SMARACT GMBH
  • 16.2.8 NANOSURF
  • 16.2.9 GINKGO BIOWORKS
  • 16.2.10 STEREOTAXIS, INC.
  • 16.2.11 BIONAUT LABS, INC.
  • 16.2.12 NOVASCAN TECHNOLOGIES, INC.
  • 16.2.13 DNA NANOBOTS, INC.
  • 16.2.14 ANGSTROM ADVANCED INC.
  • 16.2.15 NENOVISION S.R.O.

17 RESEARCH METHODOLOGY

• 17.1 RESEARCH DATA
  • 17.1.1 SECONDARY DATA
    • 17.1.1.1 List of key secondary sources
    • 17.1.1.2 Key data from secondary sources
  • 17.1.2 PRIMARY DATA
    • 17.1.2.1 List of primary interview participants
    • 17.1.2.2 Breakdown of primaries
    • 17.1.2.3 Key industry insights
  • 17.1.3 SECONDARY AND PRIMARY RESEARCH
• 17.2 MARKET SIZE ESTIMATION
  • 17.2.1 BOTTOM-UP APPROACH
    • 17.2.1.1 Approach to arrive at market size using bottom-up analysis (demand side)
  • 17.2.2 TOP-DOWN APPROACH
    • 17.2.2.1 Approach to arrive at market size using top-down analysis (supply side)
• 17.3 DATA TRIANGULATION
• 17.4 STUDY ASSUMPTIONS
• 17.5 RISK ANALYSIS
• 17.6 RESEARCH LIMITATIONS

18 APPENDIX

• 18.1 DISCUSSION GUIDE
• 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 18.3 CUSTOMIZATION OPTIONS
• 18.4 RELATED REPORTS
• 18.5 AUTHOR DETAILS

관련자료